Protalix BioTherapeutics
PLX
#8447
Rank
NZ$0.28 B
Marketcap
$3.90
Share price
3.23%
Change (1 day)
58.04%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$12.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$45.66 Million. In 2023 the company made an earning of NZ$20.44 Million, an increase over its 2022 earnings that were of -NZ$20.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$12.83 Million-162.7%
2023 NZ$20.44 M-199.05%
2022 -NZ$20.65 Million-40.38%
2021 -NZ$34.63 Million-732.31%
2020 NZ$5.47 M-130.53%
2019 -NZ$17.94 Million189.85%
2018 -NZ$6.19 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.2 Million-32.37%
2015 -NZ$47.62 Million10.11%
2014 -NZ$43.25 Million-7.59%
2013 -NZ$46.8 Million
2011 -NZ$54.19 Million-19.39%
2010 -NZ$67.22 Million20.87%
2009 -NZ$55.62 Million32.26%
2008 -NZ$42.05 Million-5.46%
2007 -NZ$44.48 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.68 Million1.03%
2000 -NZ$0.67 Million-53.22%
1999 -NZ$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$50.03 Million 270.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.89 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.07 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.5 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel